A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

The cholinergic hypothesis of geriatric memory dysfunction

Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545 · see citing works

AChE-stained horizontal sections of the rat brain in stereotaxic coordinates

Paxinos, G., WATSON, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,497 · see citing works

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · see citing works

Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections

Hefti, F. F. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02155.1986 · Cited by 1,455 · see citing works

Human Memory and the Cholinergic System

Drachman, D. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320001001 · Cited by 1,398 · see citing works

CENTRAL CHOLINERGIC SYSTEMS AND COGNITION

Everitt, B. J., & Robbins, T. W. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.649 · Cited by 1,348 · see citing works

Neuropathology of older persons without cognitive impairment from two community-based studies

Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336 · see citing works

Sex differences in Alzheimer disease — the gateway to precision medicine

for the Women’s Brain Project and the Alzheimer Precision Medicine Initiative, Ferretti, M. T., Iulita, M. F., Cavedo, E., Chiesa, P. A., Schumacher Dimech, A., Santuccione Chadha, A., Baracchi, F., Girouard, H., Misoch, S., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0032-9 · Cited by 1,009 · see citing works

Modes and models of forebrain cholinergic neuromodulation of cognition

Hasselmo, M. E., & Sarter, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.104 · Cited by 733 · see citing works

Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.

Schönbeck, U., Mach, F., & Libby, P. (1998) · PubMed · Cited by 681 · see citing works

Overview and Findings from the Religious Orders Study

Bennett, D. A., Schneider, J. A., Arvanitakis, Z., & Wilson, R. S. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322573 · Cited by 647 · see citing works

Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.

Ogata, Y., Enghild, J. J., & Nagase, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50563-4 · Cited by 633 · see citing works

Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing

Schönbeck, U., Mach, F., & Libby, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3340 · Cited by 605 · see citing works

The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.

Fahnestock, M., Michalski, B., Xu, B., & Coughlin, M. (2001) · Molecular and cellular neurosciences · doi:10.1006/mcne.2001.1016 · Cited by 482 · see citing works

The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?

Mesulam, M. (2004) · Learning & Memory · doi:10.1101/lm.69204 · Cited by 467 · see citing works

Matrix Metalloproteinase Inhibition Prevents Oxidative Stress-Associated Blood–Brain Barrier Disruption after Transient Focal Cerebral Ischemia

Gasche, Y., Copin, J., Sugawara, T., Fujimura, M., & Chan, P. H. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200112000-00003 · Cited by 388 · see citing works

Dementia in Down syndrome: unique insights for Alzheimer disease research

Lott, I. T., & Head, E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0132-6 · Cited by 383 · see citing works

Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade

Bruno, M. A., & Cuello, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510645103 · Cited by 344 · see citing works

Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase

Pearson, R. C. A., Sofroniew, M. V., Cuello, A. C., Powell, T. P. S., Eckenstein, F. P., Esiri, M. M., & Wilcock, G. K. (1983) · Brain Research · doi:10.1016/0006-8993(83)90046-x · Cited by 334 · see citing works

Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity

White, A. R., Du, T., Laughton, K. M., Volitakis, I., Sharples, R. A., Xilinas, M. E., Hoke, D. E., Holsinger, R. M. D., Evin, G., Cherny, R. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602487200 · Cited by 284 · see citing works

Effects of extracellular matrix‐degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity

Meighan, S. E., Meighan, P. C., Choudhury, P., Davis, C. J., Olson, M. L., Zornes, P. A., Wright, J. W., & Harding, J. W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03565.x · Cited by 281 · see citing works

α-Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1

Lee, E.-J., Woo, M.-S., Moon, P., Baek, M., Choi, I.-Y., Kim, W.-K., Junn, E., & Kim, H.-S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903480 · Cited by 267 · see citing works

Matrix Metalloproteinase-3: A Novel Signaling Proteinase from Apoptotic Neuronal Cells That Activates Microglia

Kim, Y. S., Kim, S. S., Cho, J. J., Choi, D. H., Hwang, O., Shin, D. H., Chun, H. S., Beal, M. F., & Joh, T. H. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4346-04.2005 · Cited by 256 · see citing works

Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation.

Gurney, K., Estrada, E. Y., & Rosenberg, G. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.006 · Cited by 243 · see citing works

Matrix metalloproteinases and free radicals in cerebral ischemia

JIANLIU, K., & Rosenberg, G. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.033 · Cited by 230 · see citing works

Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment

Ribbens, C., Porras, M., Franchimont, N., Kaiser, M.-J., Jaspar, J.-M., Damas, P., Houssiau, F. A., & Malaise, M. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.2.161 · Cited by 222 · see citing works

A Novel Transgenic Rat Model with a Full Alzheimer's-Like Amyloid Pathology Displays Pre-Plaque Intracellular Amyloid-β-Associated Cognitive Impairment

León, W., Canneva, F., Partridge, V., Allard, S., Ferretti, M. T., DeWilde, A., Vercauteren, F., Atifeh, R., Ducatenzeiler, A., Klein, W. L., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1349 · Cited by 221 · see citing works

Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses

Eckhard, U., Huesgen, P. F., Schilling, O., Bellac, C. L., Butler, G. S., Cox, J. H., Dufour, A., Goebeler, V., Kappelhoff, R., Keller, U. A. D., et al. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.09.003 · Cited by 208 · see citing works

Cytokine-regulated proteases in autoimmune diseases

Opdenakker, G., & Damme, J. V. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90151-1 · Cited by 208 · see citing works

White matter damage is associated with matrix metalloproteinases in vascular dementia

Rosenberg, G. A., Sullivan, N., & Esiri, M. M. (2001) · Stroke · doi:10.1161/01.str.32.5.1162 · Cited by 207 · see citing works

A pivotal role of matrix metalloproteinase‐3 activity in dopaminergic neuronal degeneration via microglial activation

Kim, Y. S., Choi, D. H., Block, M. L., Lorenzl, S., Yang, L., Kim, Y., Sugama, S., Cho, B. P., Hwang, O., Browne, S. E., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5865com · Cited by 199 · see citing works

Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases

Brkić, M., Balusu, S., Wonterghem, E. V., Gorlé, N., Benilova, I., Kremer, A., Hove, I. V., Moons, L., Strooper, B. D., Kanazir, S., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0006-15.2015 · Cited by 179 · see citing works

Increased Production of Matrix Metalloproteinases in Enriched Astrocyte and Mixed Hippocampal Cultures Treated with β‐Amyloid Peptides

Deb, S., & Gottschall, P. E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041641.x · Cited by 163 · see citing works

Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment

Bruno, M. A., Mufson, E. J., Wuu, J., & Cuello, A. C. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c22569 · Cited by 163 · see citing works

Nerve growth factor-induced synaptogenesis and hypertrophy of cortical cholinergic terminals.

Garofalo, L., Ribeiro‐da‐Silva, A., & Cuello, A. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2639 · Cited by 163 · see citing works

Inhibition of MMP‐3 or ‐9 suppresses lipopolysaccharide‐induced expression of proinflammatory cytokines and iNOS in microglia

Woo, M., Park, J., Choi, I., Kim, W., & Kim, H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05430.x · Cited by 160 · see citing works

Sex and gender differences in Alzheimer’s disease: current challenges and implications for clinical practice

Ferretti, M. T., Martínková, J., Biskup, E. M., Benke, T., Gialdini, G., Nedelská, Z., Rauen, K., Mantua, V., Religa, D., Hort, J., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14174 · Cited by 150 · see citing works

Amyloid β-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease

Bruno, M. A., León, W., Fragoso, G., Mushynski, W. E., Almazán, G., & Cuello, A. C. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181aed9e6 · Cited by 148 · see citing works

Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome

Iulita, M. F., & Cuello, A. C. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.010 · Cited by 135 · see citing works

Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer’s disease brain

Yoshiyama, Y., Asahina, M., & Hattori, T. (2000) · Acta Neuropathologica · doi:10.1007/pl00007428 · Cited by 128 · see citing works

Tumor Necrosis Factor-α– and Interleukin-1β–Dependent Matrix Metalloproteinase-3 Expression in Nucleus Pulposus Cells Requires Cooperative Signaling via Syndecan 4 and Mitogen-Activated Protein Kinase–NF-κB Axis

Wang, X., Wang, H., Yang, H., Li, J., Cai, Q., Shapiro, I. M., & Risbud, M. V. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.06.006 · Cited by 126 · see citing works

A novel intracellular role of matrix metalloproteinase‐3 during apoptosis of dopaminergic cells

Choi, D. H., Kim, E., Son, H. J., JOH, T. H., Kim, Y. S., Kim, D., Beal, M. F., & Hwang, O. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05399.x · Cited by 124 · see citing works

Cholinergic Involvement in Alzheimer’s Disease. A Link with NGF Maturation and Degradation

Cuello, A. C., Bruno, M. A., Allard, S., León, W., & Iulita, M. F. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9238-z · Cited by 119 · see citing works

Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease

Horstmann, S., Budig, L., Gardner, H., Koziol, J. A., Deuschle, M., Schilling, C., & Wagner, S. (2010) · International Psychogeriatrics · doi:10.1017/s1041610210000827 · Cited by 111 · see citing works

The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology

Cuello, A. C., Pentz, R., & Hall, H. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00062 · Cited by 108 · see citing works

Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease

Stomrud, E., Björkqvist, M., Janciauskiene, S. M., Minthon, L., & Hansson, O. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt44 · Cited by 105 · see citing works

Intracellular Aβ pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study

Iulita, M. F., Allard, S. T. M., Richter, L., Munter, L. M., Ducatenzeiler, A., Weise, C., Carmo, S. D., Klein, W. L., Multhaup, G., & Cuello, A. C. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-61 · Cited by 102 · see citing works

An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation

Iulita, M. F., Ower, A., Barone, C., Pentz, R., Gubert, P., Romano, C., Cantarella, R. A., Elia, F., Buono, S., Recupero, M., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.05.001 · Cited by 99 · see citing works

Overcoming neurite‐inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix

Cua, R. C., Lau, L. W., Keough, M. B., Midha, R., Apte, S., & Yong, V. W. (2013) · Glia · doi:10.1002/glia.22489 · Cited by 87 · see citing works

Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease

Iulita, M. F., Millón, M. B. B., Pentz, R., Aguilar, L. F., Carmo, S. D., Allard, S. T. M., Michalski, B., Wilson, E. N., Ducatenzeiler, A., Bruno, M. A., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.08.019 · Cited by 84 · see citing works

Matrix metalloproteinases 1, 2, and 3 from rheumatoid synovial cells are sufficient to destroy joints.

Okada, Y., Nagase, H., & Harris, E. D. (1987) · PubMed · Cited by 78 · see citing works

Sex and Gender Differences in the Brain Cholinergic System and in the Response to Therapy of Alzheimer Disease with Cholinesterase Inhibitors

Giacobini, E., & Pepeu, G. (2018) · Current Alzheimer Research · doi:10.2174/1567205015666180613111504 · Cited by 77 · see citing works

Matrix Metalloproteinase-3 Is Increased and Participates in Neuronal Apoptotic Signaling Downstream of Caspase-12 during Endoplasmic Reticulum Stress

Kim, E., Shin, E.-J., Choi, J. H., Son, H. J., Park, I., JOH, T. H., & Hwang, O. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093799 · Cited by 72 · see citing works

Interferon-γ Coordinately Upregulates Matrix Metalloprotease (MMP)-1 and MMP-3, But Not Tissue Inhibitor of Metalloproteases (TIMP), Expression in Cultured Keratinocytes

Tamai, K., Ishikawa, H., Mauviel, A., & Uitto, J. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12665857 · Cited by 72 · see citing works

NF-κB binds to a polymorphic repressor element in the MMP-3 promoter

Borghaei, R. C., Rawlings, P. L., Javadi, M., & Woloshin, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.030 · Cited by 69 · see citing works

The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease

Pentz, R., Iulita, M. F., Ducatenzeiler, A., Bennett, D. A., & Cuello, A. C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0797-2 · Cited by 68 · see citing works

TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia

Walker, E. J., & Rosenberg, G. A. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.11.022 · Cited by 67 · see citing works

Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid

Hanzel, C. E., Iulita, M. F., Eyjolfsdottir, H., Hjorth, E., Schultzberg, M., Eriksdotter, M., & Cuello, A. C. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132282 · Cited by 64 · see citing works

Differences in Susceptibility of MBP Charge Isomers to Digestion by Stromelysin-1 (MMP-3) and Release of an Immunodominant Epitope

D’Souza, C. A., & Moscarello, M. A. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9116-9 · Cited by 61 · see citing works

Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation

Nübling, G., Levin, J., Bader, B., Israel, L., Bötzel, K., Lorenzl, S., & Giese, A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.07.018 · Cited by 59 · see citing works

Endothelial stromelysin1 regulation by the forkhead box-O transcription factors is crucial in the exudative phase of acute lung injury

Artham, S., Gao, F., Verma, A., Alwhaibi, A. M., Sabbineni, H., Hafez, S. S., Ergul, A., & Somanath, P. R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.006 · Cited by 58 · see citing works

Mechanisms of NMDA Receptor- and Voltage-Gated L-Type Calcium Channel-Dependent Hippocampal LTP Critically Rely on Proteolysis That Is Mediated by Distinct Metalloproteinases

Wiera, G., Nowak, D., Hove, I. V., Dzięgiel, P., Moons, L., & Mozrzymas, J. W. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2170-16.2016 · Cited by 53 · see citing works

p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts

Sinfield, J. K., Das, A., O'Regan, D. J., Ball, S. G., Porter, K. E., & Turner, N. A. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.071 · Cited by 53 · see citing works

Stereological estimation of neuron number and plaque load in the hippocampal region of a transgenic rat model of A lzheimer's disease

Heggland, I., Storkaas, I. S., Soligard, H., Kobro‐Flatmoen, A., & Witter, M. P. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12876 · Cited by 51 · see citing works

Functional Interaction between Matrix Metalloproteinase-3 and Semaphorin-3C during Cortical Axonal Growth and Guidance

Gonthier, B., Nasarre, C., Roth, L., Perraut, M., Thomasset, N., Roussel, G., Aunis, D., & Bagnard, D. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhl082 · Cited by 50 · see citing works

Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults

Mattsson, N., Insel, P. S., Nosheny, R. L., Trojanowski, J. Q., Shaw, L. M. J., Jack, C. R., Tosun, D., & Weiner, M. W. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.027 · Cited by 49 · see citing works

Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1–42 levels

Mlekusch, R., & Humpel, C. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.043 · Cited by 49 · see citing works

Serum MMP-3 Level as a Biomarker for Monitoring and Predicting Response to Etanercept Treatment in Ankylosing Spondylitis

Arends, S., van der Veer, E., Groen, H., Houtman, P. M., Jansen, T., Leijsma, M. K., Bijzet, J., Limburg, P. C., Kallenberg, C. G. M., Spoorenberg, A. J. P. L., et al. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.101128 · Cited by 46 · see citing works

Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease

Counts, S., He, B., Prout, J. G., Michalski, B., Farotti, L., Fahnestock, M. L., & Mufson, E. J. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160129095649 · Cited by 45 · see citing works

Identification and Preliminary Validation of a Plasma Profile Associated with Cognitive Decline in Dementia and At-Risk Individuals: A Retrospective Cohort Analysis

Iulita, M. F., Ganesh, A., Pentz, R., Aguilar, L. F., Gubert, P., Ducatenzeiler, A., Christie, S., Wilcock, G. K., & Cuello, A. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180970 · Cited by 45 · see citing works

MMP‐2, ‐3 and ‐9 levels and activity are not related to Aβ load in the frontal cortex in Alzheimer's disease

Baig, S., Kehoe, P. G., & Love, S. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00897.x · Cited by 40 · see citing works

The Up-regulation of Stromelysin-1 (MMP-3) in a Spontaneously Demyelinating Transgenic Mouse Precedes Onset of Disease

D’Souza, C. A., Mak, B. C., & Moscarello, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108817200 · Cited by 39 · see citing works

Chapter 32: Trophic responses of forebrain cholinergic neurons: a discussion

Cuello, A. C. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62408-5 · Cited by 38 · see citing works

Synaptic Potentiation at Basal and Apical Dendrites of Hippocampal Pyramidal Neurons Involves Activation of a Distinct Set of Extracellular and Intracellular Molecular Cues

Brzdąk, P., Wójcicka, O., Zaręba-Kozioł, M., Minge, D., Henneberger, C., Włodarczyk, J., Mozrzymas, J. W., & Wójtowicz, T. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx324 · Cited by 34 · see citing works

Plasma gelsolin and matrix metalloproteinase 3 as potential biomarkers for Alzheimer disease

Mao, P., Jia, J., & Qin, W. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.04.014 · Cited by 33 · see citing works

Glial Cells in Health and Disease of the CNS

Rommy von Bernhardi, M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-40764-7 · Cited by 28 · see citing works

Conformational characterization of nerve growth factor-β reveals that its regulatory pro-part domain stabilizes three loop regions in its mature part

Trabjerg, E., Kartberg, F., Christensen, S., & Rand, K. D. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.803320 · Cited by 26 · see citing works

Transplantation of Fibroblasts that Overexpress Matrix Metalloproteinase-3 into the Site of Spinal Cord Injury in Rats

Pizzi, M. A., & Crowe, M. J. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.1750 · Cited by 24 · see citing works

Interaction between matrix metalloproteinase 3 and the ε4 allele of apolipoprotein E increases the risk of Alzheimer’s disease in Finns

Saarela, M., Lehtimäki, T. J., Rinne, J. O., Hervonen, A., Jylhä, M. K., Röyttä, M., Ahonen, J.-P., & Mattila, K. M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.027 · Cited by 23 · see citing works

Impact of the matrix metalloproteinase MMP-3 on dementia

Helbecque, N., Cottel, D., Hermant, X., & Amouyel, P. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.030 · Cited by 23 · see citing works

Anti-M3 muscarinic cholinergic autoantibodies from patients with primary Sjögren's syndrome trigger production of matrix metalloproteinase-3 (MMP-3) and prostaglandin E2 (PGE2) from the submandibular glands

Reina, S., Sterin‐Borda, L., Passafaro, D., & Borda, E. (2011) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2010.08.017 · Cited by 23 · see citing works

Association of biomarkers of inflammation, cartilage and bone turnover with gender, disease activity, radiological damage and sacroiliitis by magnetic resonance imaging in patients with early spondyloarthritis

Almodóvar, R., Rios, V., Ocaña, S., Gobbo, M., Casas, M. L., Zarco, P., & Juanola, X. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2349-5 · Cited by 21 · see citing works

The Structure of the Pro-domain of Mouse proNGF in Contact with the NGF Domain

Yan, R., Yalinca, H., Paoletti, F., Gobbo, F., Marchetti, L., Kuzmanic, A., Lamba, D., Gervasio, F. L., Konarev, P. V., Cattaneo, A., et al. (2018) · Structure · doi:10.1016/j.str.2018.09.013 · Cited by 20 · see citing works

Peripheral and central nervous system alterations in a rat model of inflammatory arthritis

Locke, S., Yousefpour, N., Mannarino, M., Xing, S., Yashmin, F., Bourassa, V., & Ribeiro‐da‐Silva, A. (2020) · Pain · doi:10.1097/j.pain.0000000000001837 · Cited by 20 · see citing works

Matrix Metalloprotease 3 Activity Supports Hippocampal EPSP-to-Spike Plasticity Following Patterned Neuronal Activity via the Regulation of NMDAR Function and Calcium Flux

Brzdąk, P., Włodarczyk, J., Mozrzymas, J. W., & Wójtowicz, T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9970-7 · Cited by 19 · see citing works

The Role of Galectin-3: From Oligodendroglial Differentiation and Myelination to Demyelination and Remyelination Processes in a Cuprizone-Induced Demyelination Model

Hoyos, H. C., Marder, M., Ulrich, R., Gudi, V., Stangel, M., Rabinovich, G. A., Pasquini, L. A., & Pasquini, J. M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-40764-7_15 · Cited by 19 · see citing works

TrkA antagonists decrease NGF-induced ChAT activity in vitro and modulate cholinergic synaptic number in vivo

Debeir, T., Saragovi, H. U., & Cuello, A. C. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80011-9 · Cited by 12 · see citing works

Cholinoceptor Modulation on Nitric Oxide Regulates Prostaglandin E2 and Metalloproteinase-3 Production in Experimentally Induced Inflammation of Rat Dental Pulp

Pita, A. D. C., Borda, E., Ganzinelli, S., Passafaro, D., & Sterin‐Borda, L. (2009) · Journal of Endodontics · doi:10.1016/j.joen.2009.01.004 · Cited by 12 · see citing works

Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease

Reitz, C., van Rooij, F. J. A., de Maat, M. P. M., den Heijer, T., Albert Hofman, D., Witteman, J. C. M., & Breteler, M. M. B. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.001 · Cited by 11 · see citing works

Reply

Romas (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200004)43:4

Alzheimer’s Disease: An Update and Insights Into Pathophysiology

Abubakar, M. B., Sanusi, K. O., Ugusman, A., Mohamed, W. M. Y., Kamal, H., Ibrahim, N. H., Khoo, C. S., & Kumar, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.742408 · Cited by 293 · see citing works

Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming

Sun, Z., Kwon, J.-S., Ren, Y., Chen, S., Walker, C. K., Lu, X., Cates, K., Karahan, H., Sviben, S., Fitzpatrick, J. A. J., et al. (2024) · Science · doi:10.1126/science.adl2992 · Cited by 77 · see citing works

The Role of Extracellular Matrix in Human Neurodegenerative Diseases

Pintér, P., & Alpár, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911085 · Cited by 66 · see citing works

The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology

Radošinská, D., & Radošinská, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04315-0 · Cited by 49 · see citing works

Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study

Pentz, R., Iulita, M. F., Ducatenzeiler, A., Videla, L., Benejam, B., Carmona‐Iragui, M., Blesa, R., Lleó, A., Fortea, J., & Cuello, A. C. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12229 · Cited by 40 · see citing works

Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review

Chu, D., Yang, X., Wang, J., Zhou, Y., Gu, J., Miao, J., Wu, F., & Liu, F. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385853 · Cited by 37 · see citing works

The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer’s Cholinergic Atrophy

Carmo, S. D., Kannel, B., & Cuello, A. C. (2021) · Cells · doi:10.3390/cells11010016 · Cited by 34 · see citing works

The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates

Moretto, E., Stuart, S., Surana, S., Vargas, J. N. S., & Schiavo, G. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.844211 · Cited by 32 · see citing works

Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases

Trentini, A., Manfrinato, M. C., Castellazzi, M., & Bellini, T. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081196 · Cited by 30 · see citing works

Effects of Reactive Oxygen and Nitrogen Species on TrkA Expression and Signalling: Implications for proNGF in Aging and Alzheimer’s Disease

Kropf, E., & Fahnestock, M. L. (2021) · Cells · doi:10.3390/cells10081983 · Cited by 28 · see citing works

Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease

Aksnes, M., Edwin, T. H., Saltvedt, I. T., Eldholm, R. S., Chaudhry, F. A., Halaas, N. B., Myrstad, M., Watne, L. O., & Knapskog, A. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00514-x · Cited by 20 · see citing works

Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer’s Disease Patients

Ďurmanová, V., Javor, J., Párnická, Z., Minárik, G., Ocenasova, A., Vašečková, B., Režnáková, V., Kralova, M., Hromádka, T., & Shawkatová, I. (2021) · Mediators of Inflammation · doi:10.1155/2021/5573642 · Cited by 15 · see citing works

The NGF Metabolic Pathway: New Opportunities for Biomarker Research and Drug Target Discovery

Pentz, R., & Iulita, M. F. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-74046-7_4 · Cited by 6 · see citing works

Perineuronal nets: Cruise from a honeycomb to the safety nets

John, U., Patro, N., & Patro, I. K. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.004 · Cited by 6 · see citing works

Novel targets for the treatment and prevention of Alzheimer's disease in the European population, inspiration from amyloid beta and tau protein

Wang, X., Yang, H., Zhan, D., Sun, H., Huang, Q., Zhang, Y., Lin, Y., Wei, G., Hua, F., Liu, L., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39013 · Cited by 4 · see citing works

Estrogen-mediated corneal collagen degradation in keratoconus

Chatterjee, A., Kanu, L. N., Boychev, N., Ross, A. E., Yeung, V., Venkateswaran, N., Saeed, H. N., & Ciolino, J. B. (2025) · iScience · doi:10.1016/j.isci.2025.113004 · Cited by 4 · see citing works

Homocysteine decreases VEGF, EGF, and TrkB levels and increases CCL5/RANTES in the hippocampus: Neuroprotective effects of rivastigmine and ibuprofen

Júnior, O. V. R., Silveira, J. S., Gusso, D., Prauchner, G. R. K., Deniz, B. F., de Almeida, W., Pereira, L. O., & Wyse, Â. T. D. S. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111260 · Cited by 4 · see citing works

Acetylcholine - Recent Advances and New Perspectives

Heinbockel, T. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.106304 · Cited by 3 · see citing works

The dependence of basal forebrain cholinergic neurons on NGF: The case in Alzheimer pathology

Cuello, A. C., & Carmo, S. D. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19088-9.00010-x · Cited by 2 · see citing works

Modes of Acetylcholine Signaling in the Prefrontal Cortex: Implications for Cholinergic Dysfunction and Disorders

Fecik, M. J., & Savage, L. M. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110462 · Cited by 2 · see citing works

Nerve growth factor precursor alterations in neuron‐derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum

Valle‐Tamayo, N., Aranha, M. R., Pérez‐González, R., Serrano‐Requena, S., Videla, L., Barroeta, I., Benejam, B., Chiva‐Blanch, G., Jiménez, A., Busciglio, J. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70137 · Cited by 2 · see citing works

Nerve Growth Factor Compromise in Down Syndrome

Carmo, S. D., Kannel, B., & Cuello, A. C. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.719507 · Cited by 2 · see citing works

Distinct conformational changes occur within the intrinsically unstructured pro‐domain of pro‐Nerve Growth Factor in the presence of ATP and Mg2+

Paoletti, F., Covaceuszach, S., Cassetta, A., Calabrese, A. N., Novak, U., Konarev, P. V., Grdadolnik, J., Lamba, D., & Grdadolnik, S. G. (2023) · Protein Science · doi:10.1002/pro.4563 · Cited by 2 · see citing works

ATP binding to Nerve Growth Factor (NGF) and pro-Nerve Growth Factor (proNGF): an endogenous molecular switch modulating neurotrophins activity

Paoletti, F. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231089 · Cited by 1 · see citing works

Determinants of extraction efficiency in human amniotic membrane processing: biological, mechanical, and biochemical factors shaping growth factor yield

Selver, Ö. B., Kanbur, A. S., Kocamanoglu, M., Korkmaz, İ., Atsatan, Y. K., Gürdal, M., Yıldırım, N., Wolosin, J. M., Ercan, G., Köse, T., et al. (2026) · Cell and Tissue Banking · doi:10.1007/s10561-026-10229-z · Cited by 1 · see citing works

Additional file 1 of Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease

Aksnes, M., Edwin, T. H., Saltvedt, I. T., Eldholm, R. S., Chaudhry, F. A., Halaas, N. B., Myrstad, M., Watne, L. O., & Knapskog, A.-B. (2023) · Figshare · doi:10.6084/m9.figshare.23118925

Functional Disability and MMPs in Alzheimer’s Disease

Alkanlı, N., Alkanlı, S. S., & Ay, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-40858-8_565-1

Functional Disability and MMPs in Alzheimer’s Disease

Alkanlı, N., Alkanlı, S. S., & Ay, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-11375-7_565

Associations between cerebrospinal fluid biomarkers related to endothelial dysfunction and Alzheimer’s disease

Zhu, Y.-K., Zhu, Q.-J., Wang, L. F., Hu, H., Wang, X.-J., Zhang, Z.-H., Zhang, W., Tan, L., & Hu, H. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1744647

The role of matrix metalloproteinases in Alzheimer's disease and small vessel disease

Nguyen, N., Huynh, S., Mroczko, B., & Glodzik, L. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261494579

Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment

Bruno, M. A., Mufson, E. J., Wuu, J., & Cuello, A. C. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c22569 · Cited by 163 · see citing works

The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease

Pentz, R., Iulita, M. F., Ducatenzeiler, A., Bennett, D. A., & Cuello, A. C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0797-2 · Cited by 68 · see citing works

P3–057: Matrix metalloproteinase‐3 is associated with decreased plasma gelsolin in Alzheimer's disease

Jia, J., Mao, P., & Zhang, J. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1127

Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer’s disease brain

Yoshiyama, Y., Asahina, M., & Hattori, T. (2000) · Acta Neuropathologica · doi:10.1007/pl00007428 · Cited by 128 · see citing works

Amyloid β-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease

Bruno, M. A., León, W., Fragoso, G., Mushynski, W. E., Almazán, G., & Cuello, A. C. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181aed9e6 · Cited by 148 · see citing works